Literature DB >> 2831221

Characterization of the class III collagen receptor, a phosphorylated, transmembrane glycoprotein expressed in nucleated human cells.

W G Carter1, E A Wayner.   

Abstract

We previously identified a 90-kDa cell surface glycoprotein, termed the class III collagen receptor (CRIII), that bound to collagen in affinity chromatography experiments (Wayner, E. A., and Carter, W. G. (1987) J. Cell Biol. 105, 1873-1884). Here, we utilize monoclonal antibodies to define three domains of the CRIII, hydrophobic transmembrane, phosphorylated cytoplasmic, and glycosylated extracellular. The domain designations are based on the following characteristics. (i) Differential extraction, phase partitioning with Triton X-114, and incorporation into liposomes all indicate that the CRIII is an intrinsic membrane receptor with a hydrophobic domain. After incorporation into liposomes the CRIII binds collagen. (ii) Immunofluorescence microscopy reveals that most nucleated cells express the CRIII and that after extraction with Triton X-100, the Triton-insoluble CRIII distributes in a fibrillar pattern at the cell periphery and in closed loops that partially co-distributed with vimentin. The CRIII contains phosphoserine residues which are located on a cytoplasmic domain that may interact with the cytoskeleton. (iii) The CRIII contains 25% carbohydrate in 8-10 asparagine-linked carbohydrate chains of 2800 daltons each bound to a 65-kDa core peptide in the extracellular domain. Peptide mapping with trypsin defined a glycosylated 27-kDa extracellular fragment and a phosphorylated and glycosylated 35-kDa transmembrane fragment. These data suggest a model for the CRIII that links the cytoskeleton with the extracellular matrix.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2831221

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  80 in total

1.  Expression of adhesion molecule CD44 on human corneas.

Authors:  S N Zhu; B Nölle; G Duncker
Journal:  Br J Ophthalmol       Date:  1997-01       Impact factor: 4.638

2.  Modulation of superantigen-induced T-cell deletion by antibody anti-Pgp-1 (CD44).

Authors:  E Ayroldi; L Cannarile; C Ricardi
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

3.  Isolation and characterisation of antibodies which specifically recognise the peptide encoded by exon 7 (v2) of the human CD44 gene.

Authors:  A Borgya; A Woodman; M Sugiyama; F Donié; E Kopetzki; Y Matsumura; D Tarin
Journal:  Clin Mol Pathol       Date:  1995-10

4.  Lipid raft association restricts CD44-ezrin interaction and promotion of breast cancer cell migration.

Authors:  Simona Donatello; Irina S Babina; Lee D Hazelwood; Arnold D K Hill; Ivan R Nabi; Ann M Hopkins
Journal:  Am J Pathol       Date:  2012-09-29       Impact factor: 4.307

5.  B lymphocytes express and lose syndecan at specific stages of differentiation.

Authors:  R D Sanderson; P Lalor; M Bernfield
Journal:  Cell Regul       Date:  1989-11

6.  Mapping in vivo associations of cytoplasmic proteins with integrin beta 1 cytoplasmic domain mutants.

Authors:  J M Lewis; M A Schwartz
Journal:  Mol Biol Cell       Date:  1995-02       Impact factor: 4.138

7.  Effect of transforming growth factor-beta 1 and basic fibroblast growth factor on the expression of cell surface proteoglycans in human lung fibroblasts. Enhanced glycanation and fibronectin-binding of CD44 proteoglycan, and down-regulation of glypican.

Authors:  M Romarís; A Bassols; G David
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

8.  Localization of CD44, the hyaluronate receptor, on the plasma membrane of osteocytes and osteoclasts in rat tibiae.

Authors:  H Nakamura; S Kenmotsu; H Sakai; H Ozawa
Journal:  Cell Tissue Res       Date:  1995-05       Impact factor: 5.249

9.  Expression of cell adhesion molecules alpha-2, alpha-5 and alpha-6 integrin, E-cadherin, N-CAM and CD-44 in renal cell carcinomas. An immunohistochemical study.

Authors:  H J Terpe; K Tajrobehkar; U Günthert; M Altmannsberger
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

Review 10.  CD44 in cancer progression: adhesion, migration and growth regulation.

Authors:  R Marhaba; M Zöller
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.